New Research targets Cancer Prevention

The global pharmaceutical industry is worth trillions and spends billions on research to find successful cancer treatments that can be patented and marketed. Unfortunately, the general research impetus sponsored by the pharma industry is not to find preventative drugs for pre-cancerous states, but rather to find curative drugs for cancers that are already active in patients. The reason for this is that it is far cheaper…

immunotherapy

Immunotherapy News

A new immunotherapy, (CAR-T) treatment has been developed for advanced leukaemia in children and young adults where prior standard treatment has failed. Dr. Tim Cripe, a specialist oncologist at Nationwide Children’s Hospital in Ohio, described the experimental therapy CTL019 produced by Swiss pharma company Novartis as “the most exciting thing I’ve seen in my lifetime.”…